Preventing cross-contamination in cell therapy production

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Preventing cross-contamination in cell therapy production

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

For production of human cells for cell therapy, a contamination control strategy (CCS) is required as part of current Good Manufacturing Practices (cGMP). Evidence of successful CCS approaches will go a long way towards ensuring safety, purity, efficacy, and quality of a cell therapy.

In this webinar, we will delve into the latest advancements in preventing cross-contamination during cell therapy production. The presentation will explore how the integration of cutting-edge technologies, such as the G-Rex® bioreactor from ScaleReady and the Heracell™ Vios™ CR CO2 incubators from Thermo Fisher, can significantly enhance contamination control strategies (CCS) in compliance with current Good Manufacturing Practices (CGMP). We will provide attendees with practical insights into how these technologies can be applied to meet the stringent requirements of CGMP, ultimately ensuring the production of safe, pure, and effective cell therapies.

Hone your Contamination Control Strategy (CCS) to ensure GMP compliance
Understand how culturing T cells or NK cells in a closed system bioreactor can help reduce the risk of contamination.
Find out how to achieve a high-yield, high-quality production method for immunotherapy

Josh Ludwig

Global Director at Scaleready

Josh Ludwig leads commercial operations as the global director for ScaleReady. He closely collaborates with the EMEA commercial and leadership teams to ensure ScaleReady addresses the longstanding industry need for a truly scalable and practical solution. Josh has more than a decade of experience in commercial leadership and business development in the medical device industry with a specific focus on engaging directly with customers and achieving customer and company goals.

Before ScaleReady, Josh spent more than seven years supporting technical and business development at Wilson Wolf, a founding partner of ScaleReady. He successfully established protocols and executed all aspects of global business development, customer service, and marketing efforts. Josh’s career in Life Sciences began by obtaining a Bachelor of Science in biology and a minor in chemistry from the University of St. Thomas.

Mary Kay Bates

Senior Global Cell Culture Scientist at Thermo Fisher Scientific

Mary Kay Bates is a Senior Global Cell Culture Scientist with Thermo Fisher Scientific, where she provides cell culture and equipment expertise to colleagues and customers across laboratory and cleanroom settings, and at conferences. Her knowledge is based on twenty years of experience in academic and industrial cell and molecular biology labs, focusing on cancer and gene therapy. Mary Kay holds an M.S. in microbiology from the University of Wisconsin-Madison and has authored numerous publications.

You have registered for this webinar